Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/13/2007US20070287701 6-({[(1-{2-[6-(methyloxy)-1,5-naphthyridin-4-yl]ethyl}-3-pyrrolidinyl)methyl]amino}methyl)-2H-pyrido[3,2-b][1,4]thiazin-3(4H)-one; bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
12/13/2007US20070287700 Polycyclic agents for the treatment of respiratory syncytial virus infections
12/13/2007US20070287699 Antiviral agents
12/13/2007US20070287698 Tetrahydrobenzo(D)Azepin-2-One Derivatives and the Use Thereof for Treating Cardiovascular Diseases
12/13/2007US20070287697 Cgrp Receptor Antagonists
12/13/2007US20070287696 ligands for Calcitonin gene related peptide; azepinone ligands; migranes; N-[5-(2,3-Difluorophenyl)-1-(2-methoxyethyl)-2-oxopiperidin-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide
12/13/2007US20070287695 Novel Compounds
12/13/2007US20070287694 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
12/13/2007US20070287693 Benzamide Derivatives That Act Upon The Glucokinase Enzyme
12/13/2007US20070287692 Aspartyl protease inhibitors
12/13/2007US20070287691 Administering diacylglycerol as an antidiabetic agent to lower the homeostasis model assessment index ratio (HOMA-R); accumulation of fatty acids in the small intestine to promote beta-oxidation; prevent triglyceride formation; lower blood remnant-like lipoproteins/leptin levels; cardiovascular diorders
12/13/2007US20070287690 Compositions and methods comprising a thiazide diuretic and a mineralocorticoid inhibitor
12/13/2007US20070287689 Therapeutic And/Or Preventive Agents For Chronic Skin Diseases
12/13/2007US20070287688 Pharmaceutical Compositions for Topical Application
12/13/2007US20070287687 Method for removing debris from tooth and bone surfaces using irrigation solution
12/13/2007US20070287686 hair treatment; oxidation color dyes
12/13/2007US20070287685 Medicinal composition containing FBPase inhibitor
12/13/2007US20070287684 Methods and compositions for treating trauma-hemorrhage using estrogen and derivatives thereof
12/13/2007US20070287683 Low molecular weight heparin composition and uses thereof
12/13/2007US20070287682 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
12/13/2007US20070287681 siRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof
12/13/2007US20070287680 Combined Active and Passive Targeting of Biologically Active Agents
12/13/2007US20070287677 Rad51 Expression Inhibitors, Pharmaceutical Agents Containing The Inhibitors As Active Ingredients, And Uses Thereof
12/13/2007US20070287676 Diagnosis and treatment of endometriosis
12/13/2007US20070287675 Enhanced Delivery of Drug Compositions to Treat Life Threatening Infections
12/13/2007US20070287674 New treatment of diabetes mellitus
12/13/2007US20070287673 Monosaccharide derivatives
12/13/2007US20070287672 Macromolecular Gsh-Activiated Glyoxylase I Inhibitors
12/13/2007US20070287669 Combined Use of Derivatives of GLP-1 Analogs and PPAR Ligands
12/13/2007US20070287664 Combinations of HCV protease inhibitor(s) and CYP3A4 inhibitor(s), and methods of treatment related thereto
12/13/2007US20070287663 Glycopeptide Composition with Improved Antibiotic Activity
12/13/2007US20070287632 Sulphur-Containing Oils For Controlling Plant Pathogens And Stimulating Nutrient Uptake
12/13/2007US20070287175 Sirna That Inhibits Wt1 Gene Expression And Uses Thereof
12/13/2007US20070287153 Methods for the identification and validation of functional intracellular targets with intramers or in vivo selection
12/13/2007US20070286914 having as its major glycosyl components glucose, galactose, mannose and arabinose
12/13/2007US20070286912 Method for promoting eye health
12/13/2007US20070286911 Huperzia serrate (thunb.) trev. composition comprising compounded huperzine a and huperzine b and methods for preparing it
12/13/2007US20070286909 Amino acid compositions
12/13/2007US20070286906 Dihydrobenzoquinone compounds
12/13/2007US20070286905 Method for the Preparation of Trans-or Cis-Diammoniumdichlorodihydroxoplatinum(IV) and the Use Thereof in the Production of Pharmaceutical Active Substances
12/13/2007US20070286902 Dosage forms comprising a short acting sedative-hypnotic or salt thereof
12/13/2007US20070286901 Novel Pharmaceutical Formulation of Cefixime for Enhanced Bioavailability
12/13/2007US20070286900 Low dose tablets of opioid analgesics and preparation process
12/13/2007US20070286897 Liposomal Formulations of Anthracycline Agents and Cytidine Analogs
12/13/2007US20070286896 Therapeutic or Diagnostic Drug for Inflammatory Disease Comprising Targeting Liposome
12/13/2007US20070286892 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals
12/13/2007US20070286890 Eyelash applicator and method
12/13/2007US20070286889 Weight management system for obese animals
12/13/2007US20070286887 Fine powder of amino acid and suspension thereof
12/13/2007US20070286884 Implantable microbial cellulose materials for hard tissue repair and regeneration
12/13/2007US20070286882 Solvent systems for coating medical devices
12/13/2007US20070286881 Method, composition and kit for treating degenerated disc disease and discogenic pain
12/13/2007US20070286876 Skin care compositions comprising low concentrations of skin treatment agents
12/13/2007US20070286875 Oral liquid loratadine formulations and methods
12/13/2007US20070286869 Influenza virus vaccine composition and methods of use
12/13/2007US20070286867 Combination Therapy
12/13/2007US20070286864 Treating non-small cell lung cancer (NSCLC), pancreatic, colon or breast cancer tumors or tumor metastases; using erlotinib HCl (also known as TARCEVA); 3-Phosphoinositide-dependent protein kinase 1 (PDK1) inhibitor
12/13/2007US20070286863 CMKLR regulation of adipogenesis and adipocyte metabolic function
12/13/2007US20070286862 Cancer Associated Antigens
12/13/2007US20070286856 Enzyme is a drug target; cancer, inflammatory diseases such as psoriasis
12/13/2007US20070286853 Diagnostics and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Delta (Ppard)
12/13/2007US20070286851 Method of Identifying Modulators of NOGO-Functions
12/13/2007US20070286843 Recombinant Polypeptides of the Members of the Tnf Ligand Family and Use Thereof
12/13/2007US20070286842 serine protease inhibitors, for the treatment of hepatitis c virus infections
12/13/2007US20070286841 Method for lowering serum glucose
12/13/2007US20070286840 generation of NO from a C-based diazeniumdiolate that is covalently attached to a phenyl-containing polymer( polystyrene homo or copolymer, polyethyene terephthalate, polyamides etc.) without the possibility to form nitrosamines; of vascular stents, vascular grafts, catheters, wound dressings, bandages
12/13/2007US20070286838 Tamanu Oil Products
12/13/2007US20070286835 Skin external preparation having hexagonal gel structure
12/13/2007US20070286823 Compositions having anti-dental caries function
12/13/2007US20070286822 Compounds for the Treatment of Periodontal Disease
12/13/2007US20070286819 Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailability
12/13/2007US20070286818 Treating cystic fibrosis with antibiotics via an aerosol drug
12/13/2007US20070286817 Treating cystic fibrosis with antibiotics via a swirler delivery
12/13/2007US20070286814 Stable aerosol pharmaceutical formulations
12/13/2007US20070286813 Nasal formulation
12/13/2007US20070286812 Nasal formulation
12/13/2007US20070286807 Method Of Inducing Or Modulating Immune Response
12/13/2007US20070286806 Methods and Compositions for Modulating a Steroid Receptor
12/13/2007US20070286801 2-[18F]fluoro-4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide; imaging probes (11C, 123I, 125I, 73Se, 76Br, 77Br, 18F, deuterium) for positron emission tomography (PET); greater sensitivity, resolution; quantitative measurement; antiinflammatory agent, disorder with elevated cyclooxygenase-2 level
12/13/2007US20070283977 Composition comprising novel polyurethanes and cosmetic treatment process
12/13/2007DE19529057B4 Ifosfamid-Lyophilisat-Zubereitungen Ifosfamide lyophilized preparations
12/13/2007DE102006027163A1 Substituierte Benzoxazole Substituted benzoxazole
12/13/2007DE102006027156A1 New sulfimide compounds are protein kinase inhibitors useful to treat e.g. cancer, Hodgkin's lymphoma, Kaposi's sarcoma, cardiovascular disease, Crohn's disease, endometriosis and hemangioma
12/13/2007DE102006026585A1 Substituierte 4-Aryl-1,4-dihydro-1,6-naphthyridine und ihre Verwendung Substituted-4-aryl-1,4-dihydro-1,6-naphthyridines and their use
12/13/2007DE102006026583A1 Aryl-substituierte hetero-bicyclische Verbindungen und ihre Verwendung Aryl-substituted hetero-bicyclic compounds and their use
12/13/2007DE102004040014B4 Aureonitrile, Verfahren zu ihrer Herstellung und ihre Verwendung Aureonitrile, processes for their preparation and their use
12/13/2007CA2771971A1 Gene involved in immortalization of human cancer cell and use thereof
12/13/2007CA2688485A1 Phenyl pyrrole aminoguanidine derivatives
12/13/2007CA2687124A1 Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia
12/13/2007CA2687118A1 Methods of using low-dose doxepin for the improvement of sleep
12/13/2007CA2660780A1 Eyelash applicator and method
12/13/2007CA2660667A1 2,5-disubstituted piperidines
12/13/2007CA2659701A1 Benzoxazole and benzothiazole derivatives as 5-hydroxytrytamine-6 ligands
12/13/2007CA2657947A1 Fkbp-l and uses thereof
12/13/2007CA2657590A1 Treatment of excess sebum production
12/13/2007CA2655273A1 Combination of somatostatin-analogs with dopamine- or growth hormone receptor antagonist
12/13/2007CA2655225A1 Benzimidazoles and their use for the treatemnt of diabetes
12/13/2007CA2654978A1 Gene involved in immortalization of human cancer cell and use thereof
12/13/2007CA2654631A1 Modulation of the immune system by inositol phospholipids
12/13/2007CA2654608A1 Compositions and methods to enhance reverse cholesterol transport
1 ... 3461 3462 3463 3464 3465 3466 3467 3468 3469 3470 3471 3472 3473 3474 3475 3476 3477 3478 3479 3480 3481 ... 7860